This company has been marked as potentially delisted and may not be actively trading. Jupiter Neurosciences (JUNS) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesTrendsBuy This Stock Get the Latest News and Ratings for JUNS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Jupiter Neurosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JUNS Analyst Ratings Over TimeTypeCurrent Forecast9/6/24 to 9/6/251 Month Ago8/7/24 to 8/7/253 Months Ago6/8/24 to 6/8/251 Year Ago9/7/23 to 9/6/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s) N/A Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s) N/A Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s) N/A Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s) N/A Consensus Price TargetN/AN/AN/AN/AForecasted UpsideN/AN/AN/AN/AConsensus RatingStrong BuyStrong BuyStrong BuyN/A JUNS Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History JUNS Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Jupiter Neurosciences Stock vs. The CompetitionTypeJupiter NeurosciencesMedical CompaniesS&P 500Consensus Rating Score 4.00 2.78 2.53Consensus RatingStrong BuyModerate BuyModerate BuyPredicted UpsideN/A16,047.35% Upside10.35% UpsideNews Sentiment RatingPositive NewsSee Recent JUNS NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails12/19/2024Greenridge GlobalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingW. Gregozeski Not RatedUpgradeStrong-BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:52 AM ET. JUNS Forecast - Frequently Asked Questions Should I buy or sell Jupiter Neurosciences stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Jupiter Neurosciences in the last twelve months. There is currently 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" JUNS shares. Does Jupiter Neurosciences's stock price have much downside? According to analysts, Jupiter Neurosciences's stock has a predicted downside of -100.00% based on their 12-month stock forecasts. Do Wall Street analysts like Jupiter Neurosciences more than its competitors? Analysts like Jupiter Neurosciences more than other "medical" companies. The consensus rating for Jupiter Neurosciences is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how JUNS compares to other companies. Stock Forecasts and Research Tools Related Companies OmniAb Stock Forecast Enanta Pharmaceuticals Stock Forecast MediWound Stock Forecast Journey Medical Stock Forecast Achieve Life Sciences Stock Forecast Profound Medical Stock Forecast Protara Therapeutics Stock Forecast Avalo Therapeutics Stock Forecast Corbus Pharmaceuticals Stock Forecast Avita Medical Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:JUNS) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jupiter Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jupiter Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JUNS Stock Alerts